🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 03835T200 (prev. 03835T101 )
- Market Cap
- Mid Cap
- Previous Symbol
- APTO (changed 4/2/2025)
- Previous Name
- Lorus Therapeutics, Inc.
Business: Aptose Biosciences, Inc. is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. Aptose is advancing new therapeutics focused on novel cellular targets on the leading edge of cancer research coupled with companion diagnostics to identify the optimal patient population for our products. The company's small molecule cancer therapeutics pipeline includes products designed to provide additive or synergistic efficacy with existing anti-cancer therapies and regimens without overlapping toxicities.
Company Contact
- CEO
- William G. Rice, Ph.D.
- CFO
- Fletcher Payne
- Headquarters
- 66 Wellington Street West Suite 5300, Toronto, Ontario, Canada, M2J 4R3
- Phone
- 647-479-9828
- Investor Relations
- Susan Pietropaolo · 201-923-2049 · spietropaolo@aptose.com